ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Articles tagged "Renal function"

  • 2020 American Transplant Congress

    Determinants of Cardiovascular Benefit Observed in a Population with a Functioning Renal Transplant versus Patients Undergoing Chronic Dialysis

    J. Sleiman, C. Castellaro, G. Laham, M. Schiavone, M. Biain, L. Brukman, G. Soler Pujol, C. Diaz

    Nephrology, CEMIC, Caba, Argentina

    *Purpose: Patients (pts) with end stage renal disease have a high morbidity and mortality rate, mostly due to cardiovascular events (CV). Transplantation (Tx) improves survival…
  • 2020 American Transplant Congress

    Pancreas Transplant in Chronic Kidney Disease for Type 1 Diabetic Patients

    R. A. Choudhury, D. Yoeli, H. B. Moore, H. Yaffe, K. D. Conzen, T. L. Nydam, P. T. Kennealey

    Department of Surgery- Division of Transplantation Surgery, University of Colorado Hospital, Aurora, CO

    *Purpose: Although both pancreas transplantation alone (PTA) and islet cell transplantation (ICT) have been associated with peri-operative declines in eGFR, the magnitude of decline is…
  • 2020 American Transplant Congress

    Outcomes of De Novo Belatacept-Based Immunosuppression in Recipients of Kidneys at High Risk for Delayed Graft Function in the Setting of Lymphocyte Depleting Immune Modulation

    T. L. Shertel1, M. A. Wynd1, M. A. Pereiras1, J. T. McKeen1, Y. Y. Yushkov2, B. R. Schleich3, S. E. Geatrakas2, A. Patel2, M. J. Goldstein2

    1Pharmacy, Hackensack University Medical Center, Hackensack, NJ, 2Organ Transplant, Hackensack University Medical Center, Hackensack, NJ, 3Patient Safety and Quality, Hackensack University Medical Center, Hackensack, NJ

    *Purpose: Our center created an immunosuppression protocol using de novo belatacept (DNB) in the setting of lymphocyte depletion to increase the utilization of deceased donor…
  • 2020 American Transplant Congress

    Does Donor Terminal, Admission or Best Estimate Glomerular Filtration Rate Predicts Kidney Transplantation Outcomes

    G. Irish1, T. Coates2, P. Clayton2

    1Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute, Adelaide, Australia, 2Central and Northern Adelaide Renal and Transplantation Services, Royal Adelaide Hospital, Adelaide, Australia

    *Purpose: When assessing deceased kidney donors, a key factor is donor kidney function. It is unclear whether terminal, admission, or the best of terminal and…
  • 2020 American Transplant Congress

    Trajectories of Glomerular Filtration Rate and Progression to End Stage Renal Disease after Kidney Transplantation

    M. Raynaud1, O. Aubert1, P. Reese2, M. Naesens3, D. Glotz1, C. Legendre1, S. Jordan4, M. Stegall5, D. Segev6, C. Lefaucheur1, A. Loupy, On behalf of the study NCT034740031

    1Paris Transplant Group, Paris, France, 2University of Pennsylvania, Philadelphia, PA, 3Department of Transplantation, Leuven, Belgium, 4Cedars Sinai, Los Angeles, CA, 5Mayo Clinic, Rochester, MN, 6Johns Hopkins, Baltimore, MD

    *Purpose: Although the current gold standard of monitoring kidney transplant function relies on glomerular filtration rate (GFR) assessment, little is known about GFR trajectories after…
  • 2020 American Transplant Congress

    Successful Transplantation Outcomes Utilizing Deceased Donorswith Acute Kidney Injury

    A. Harshman, L. Preczewski, M. Muldoon, G. Guerra

    Kidney and Kidney/Pancreas Transplant, Miami Transplant Institute, Miami, FL

    *Purpose: Kidneys from deceased donors with acute kidney injury (AKI) are discarded at a higher rate than those without AKI, exacerbating the organ shortage crisis.…
  • 2020 American Transplant Congress

    Conversion to Belatacept in HIV(+) Renal Transplant Recipients

    A. Santeusanio, A. Bhansali, R. Shapiro, G. De Boccardo

    Mount Sinai Hospital, New York, NY

    *Purpose: HIV(+) renal transplant recipients were excluded from phase III trials of belatacept, and currently there are only scattered case reports.*Methods: This was a single…
  • 2020 American Transplant Congress

    Delayed Graft Function Adversely Affects Long-Term Survival for Kidney Recipients after Non-Renal Solid-Organ Transplantation

    J. A. Reyes, C. Blanton, M. Eerhart, G. Leverson, P. Chlebeck, Y. Yankol, L. Fernandez

    Surgery, University of Wisconsin, Madison, WI

    *Purpose: End-stage renal disease (ESRD) frequently develops after nonrenal solid-organ transplantation, increasing the number of patients with a prior heart, liver or lung transplant on…
  • 2020 American Transplant Congress

    Belatacept Conversion: Are Patients BENEFIT-ing

    R. Crew, S. Mohan, S. S. Patel

    Columbia University Irving Medical Center, New York, NY

    *Purpose: Belatacept is increasingly used in renal transplant recipients experiencing adverse effects from calcineurin inhibitors(CNI) despite limited medium- and long- term data on safety and…
  • 2020 American Transplant Congress

    Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Therapy Prior to Kidney Transplantation Does Not Impact Recovery of Function

    G. R. Bohan1, J. Trofe-Clark1, T. Fallah1, M. Norris1, R. D. Bloom2, D. Sawinski2, G. Malat1

    1Pharmacy, Hosp of Univ of Pennsylvania, Philadelphia, PA, 2Renal Div, Univ of Pennsylvania, Philadelphia, PA

    *Purpose: The impact of chronically administered medications for renin-angiotensin-aldosterone blockade (e.g. ACE-I, ARB), taken prior to kidney transplant (KTx), on immediate allograft function is unknown.*Methods:…
  • 1
  • 2
  • 3
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.

    Visit Our Partner Sites

    American Transplant Congress (ATC)

    Visit the official site for the American Transplant Congress »

    American Journal of Transplantation

    The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

    American Society of Transplantation (AST)

    An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

    American Society of Transplant Surgeons (ASTS)

    The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

    Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

    Privacy Policy

    This site uses cookies: Find out more.